Press release
Cell Line Development Market Set for Rapid growth| Key Players: GE Healthcare, Sigma-Aldrich, Cytovance Biologics, WuXi AppTec
Global Cell Line Development Market set to exceed USD 7.5 billion by 2024; according to a new research report by Global Market Insights.
Rising incidence of chronic diseases such as cancer, autoimmune disease and inflammatory disorders will drive the global cell line development market during the forecast period. Rapidly growing geriatric population base and unmet need for cancer drugs are the key factors that will fuel the demand for discovery of new drugs, thereby accelerating cell line development industry growth. Increasing adoption of cell line systems for production of vaccines, monoclonal antibodies and lymphokines will boost the demand for cell line cultures. Developments in biotechnology industry coupled with rapidly growing vaccine production across the globe will augment the cell line development market growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/429
Advancement in cell line development technologies will serve to be another positive impact rendering factor surging industry growth. Availability of automated screening methods, improved expression systems as well as developments in equipment will further stimulate industry growth. Furthermore, increasing investment in R&D to develop novel technologies and products will upsurge the cell line development market growth. However, stringent regulatory framework for approval of biologics and diagnostic products may hamper the cell line development market growth. Issues related to harvesting human embryonic stem cells that cause destruction of human embryos will further impede the market growth.
Equipment segment is estimated to show lucrative CAGR of 13.1% over the forecast period owing to advancements in cell line development technologies. Rapid development in recombinant protein therapeutic products and improvement in speed and ease of cell line production techniques will fuel the demand for incubators, centrifuges, bioreactors, microscopes and other equipment. Increasing need for safety equipment in cell culture laboratories to eliminate exposure to harmful substances will drive the segmental growth in coming years.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• GE Healthcare
• Sigma-Aldrich
• Cytovance Biologics
• WuXi AppTec
• Sartorius Stedim Biotech
• Selexis SA
• EuBiologics co.,Ltd
• Paragon Bioservices, Inc.
• Cobra Biologics
• Patheon
• Samsung BioLogics
• GVK BIO
• Cellforcure
• Epistem Ltd.Catalent Applied Drug Delivery Institute
• Bioceros
• Abzena
• Cyagen US Inc.
Recombinant cell lines segment dominated the cell line development market with USD 1.0 billion revenue in 2017 and is projected to witness healthy growth during the analysis period. Increasing demand for recombinant cell lines due to developments in rDNA technology is the major factor that will drive the segmental growth. Growing utilization of recombinant cell lines for production of biosimilars and monoclonal antibodies will upsurge the segmental growth during the forthcoming years.
Drug discovery segment is estimated to witness 12.8% CAGR over the analysis timeframe. The segment growth is highly attributable to development in application of genomics and molecular pharmacology in drug discovery. Growing prevalence of cancer, autoimmune diseases, inflammatory disorders and other chronic diseases will fuel the need for drug discovery. Furthermore, increasing adoption of cell line products for drug screening and lead validation assays will accelerate segmental growth in the coming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/429
U.S. market accounted for USD 1.0 billion in 2017 and is estimated to show similar growth during the analysis period. Increasing prevalence of chronic disease and growing adoption of cell culture techniques are the key factors that will drive the cell line development industry growth. Huge investment in R&D for development of stable cell lines and technological innovations for creating new cell lines will further boost the market growth. Key industry players in the cell line development market have strong foothold in the U.S. that will elevate the regional growth during the forthcoming years.
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
Rising incidence of chronic diseases such as cancer, autoimmune disease and inflammatory disorders will drive the global cell line development market during the forecast period. Rapidly growing geriatric population base and unmet need for cancer drugs are the key factors that will fuel the demand for discovery of new drugs, thereby accelerating cell line development industry growth. Increasing adoption of cell line systems for production of vaccines, monoclonal antibodies and lymphokines will boost the demand for cell line cultures. Developments in biotechnology industry coupled with rapidly growing vaccine production across the globe will augment the cell line development market growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/429
Advancement in cell line development technologies will serve to be another positive impact rendering factor surging industry growth. Availability of automated screening methods, improved expression systems as well as developments in equipment will further stimulate industry growth. Furthermore, increasing investment in R&D to develop novel technologies and products will upsurge the cell line development market growth. However, stringent regulatory framework for approval of biologics and diagnostic products may hamper the cell line development market growth. Issues related to harvesting human embryonic stem cells that cause destruction of human embryos will further impede the market growth.
Equipment segment is estimated to show lucrative CAGR of 13.1% over the forecast period owing to advancements in cell line development technologies. Rapid development in recombinant protein therapeutic products and improvement in speed and ease of cell line production techniques will fuel the demand for incubators, centrifuges, bioreactors, microscopes and other equipment. Increasing need for safety equipment in cell culture laboratories to eliminate exposure to harmful substances will drive the segmental growth in coming years.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• GE Healthcare
• Sigma-Aldrich
• Cytovance Biologics
• WuXi AppTec
• Sartorius Stedim Biotech
• Selexis SA
• EuBiologics co.,Ltd
• Paragon Bioservices, Inc.
• Cobra Biologics
• Patheon
• Samsung BioLogics
• GVK BIO
• Cellforcure
• Epistem Ltd.Catalent Applied Drug Delivery Institute
• Bioceros
• Abzena
• Cyagen US Inc.
Recombinant cell lines segment dominated the cell line development market with USD 1.0 billion revenue in 2017 and is projected to witness healthy growth during the analysis period. Increasing demand for recombinant cell lines due to developments in rDNA technology is the major factor that will drive the segmental growth. Growing utilization of recombinant cell lines for production of biosimilars and monoclonal antibodies will upsurge the segmental growth during the forthcoming years.
Drug discovery segment is estimated to witness 12.8% CAGR over the analysis timeframe. The segment growth is highly attributable to development in application of genomics and molecular pharmacology in drug discovery. Growing prevalence of cancer, autoimmune diseases, inflammatory disorders and other chronic diseases will fuel the need for drug discovery. Furthermore, increasing adoption of cell line products for drug screening and lead validation assays will accelerate segmental growth in the coming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/429
U.S. market accounted for USD 1.0 billion in 2017 and is estimated to show similar growth during the analysis period. Increasing prevalence of chronic disease and growing adoption of cell culture techniques are the key factors that will drive the cell line development industry growth. Huge investment in R&D for development of stable cell lines and technological innovations for creating new cell lines will further boost the market growth. Key industry players in the cell line development market have strong foothold in the U.S. that will elevate the regional growth during the forthcoming years.
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
